This suggests that this mutagenic process, which is caused by ROS in other settings42,43 (though not proven in neuroblastoma), may promote evolution and heterogeneity, as many driver SNVs, such as ALK mutations, are later events in neuroblastoma11,34. The gene discussed is ALK; the disease is neuroblastoma.